The content of middle-weight molecules in the peripheral blood of patients with brain tumors of different histostructure
Background. In tumor processes in the body the local inflammatory reactions occur, antitumor immunity is impaired and various low-molecular factors level increases in peripheral blood, particular middle-weight molecules (MWM).The content and nature of these substances depends on the chara...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Romodanov Neurosurgery Institute
2017-09-01
|
| Series: | Ukrainian Neurosurgical Journal |
| Online Access: | https://theunj.org/article/view/112092 |
| _version_ | 1797350279334592512 |
|---|---|
| author | Nikolai I. Lisyanyi Ludmila N. Belskaya Diana N. Stanetskaya Antonina I. Potapova |
| author_facet | Nikolai I. Lisyanyi Ludmila N. Belskaya Diana N. Stanetskaya Antonina I. Potapova |
| author_sort | Nikolai I. Lisyanyi |
| collection | DOAJ |
| description |
Background. In tumor processes in the body the local inflammatory reactions occur, antitumor immunity is impaired and various low-molecular factors level increases in peripheral blood, particular middle-weight molecules (MWM).The content and nature of these substances depends on the characteristics of pathological processes in the body.Aim was to determine the blood MWM level in patients with brain tumors.Materials and methods. The study included 39 blood samples of patients with brain tumors and 11 blood samples of healthy people. MWM level was determined by NI Gabrielyan method with spectrophotometric determination at a wave length of 254 and 280 nm. The results were processed using statistical methods.Results. The patients with brain tumors were found to have increased MWM level in peripheral blood compared to healthy individuals, especially when set at 254 nm. MWM level depended on tumors histostructure with slightly higher concentration in glial tumors and pituitary adenomas compared to meningioma and metastases.Conclusion. MWM level in the blood of patients with brain tumors depends on tumor nature and may serve as an indicator of inflammatory and metabolic processes in the body in the combined modality treatment of brain tumors. |
| first_indexed | 2024-03-08T12:42:34Z |
| format | Article |
| id | doaj.art-88ed2be30ef84a0a81b2e889ea55c277 |
| institution | Directory Open Access Journal |
| issn | 2663-9084 2663-9092 |
| language | English |
| last_indexed | 2024-03-08T12:42:34Z |
| publishDate | 2017-09-01 |
| publisher | Romodanov Neurosurgery Institute |
| record_format | Article |
| series | Ukrainian Neurosurgical Journal |
| spelling | doaj.art-88ed2be30ef84a0a81b2e889ea55c2772024-01-21T08:27:08ZengRomodanov Neurosurgery InstituteUkrainian Neurosurgical Journal2663-90842663-90922017-09-013141710.25305/unj.112092The content of middle-weight molecules in the peripheral blood of patients with brain tumors of different histostructureNikolai I. Lisyanyi0Ludmila N. Belskaya1Diana N. Stanetskaya2Antonina I. Potapova3Romodanov Neurosurgery Institute, Kyiv, UkraineRomodanov Neurosurgery Institute, Kyiv, UkraineRomodanov Neurosurgery Institute, Kyiv, UkraineRomodanov Neurosurgery Institute, Kyiv, Ukraine Background. In tumor processes in the body the local inflammatory reactions occur, antitumor immunity is impaired and various low-molecular factors level increases in peripheral blood, particular middle-weight molecules (MWM).The content and nature of these substances depends on the characteristics of pathological processes in the body.Aim was to determine the blood MWM level in patients with brain tumors.Materials and methods. The study included 39 blood samples of patients with brain tumors and 11 blood samples of healthy people. MWM level was determined by NI Gabrielyan method with spectrophotometric determination at a wave length of 254 and 280 nm. The results were processed using statistical methods.Results. The patients with brain tumors were found to have increased MWM level in peripheral blood compared to healthy individuals, especially when set at 254 nm. MWM level depended on tumors histostructure with slightly higher concentration in glial tumors and pituitary adenomas compared to meningioma and metastases.Conclusion. MWM level in the blood of patients with brain tumors depends on tumor nature and may serve as an indicator of inflammatory and metabolic processes in the body in the combined modality treatment of brain tumors.https://theunj.org/article/view/112092 |
| spellingShingle | Nikolai I. Lisyanyi Ludmila N. Belskaya Diana N. Stanetskaya Antonina I. Potapova The content of middle-weight molecules in the peripheral blood of patients with brain tumors of different histostructure Ukrainian Neurosurgical Journal |
| title | The content of middle-weight molecules in the peripheral blood of patients with brain tumors of different histostructure |
| title_full | The content of middle-weight molecules in the peripheral blood of patients with brain tumors of different histostructure |
| title_fullStr | The content of middle-weight molecules in the peripheral blood of patients with brain tumors of different histostructure |
| title_full_unstemmed | The content of middle-weight molecules in the peripheral blood of patients with brain tumors of different histostructure |
| title_short | The content of middle-weight molecules in the peripheral blood of patients with brain tumors of different histostructure |
| title_sort | content of middle weight molecules in the peripheral blood of patients with brain tumors of different histostructure |
| url | https://theunj.org/article/view/112092 |
| work_keys_str_mv | AT nikolaiilisyanyi thecontentofmiddleweightmoleculesintheperipheralbloodofpatientswithbraintumorsofdifferenthistostructure AT ludmilanbelskaya thecontentofmiddleweightmoleculesintheperipheralbloodofpatientswithbraintumorsofdifferenthistostructure AT diananstanetskaya thecontentofmiddleweightmoleculesintheperipheralbloodofpatientswithbraintumorsofdifferenthistostructure AT antoninaipotapova thecontentofmiddleweightmoleculesintheperipheralbloodofpatientswithbraintumorsofdifferenthistostructure AT nikolaiilisyanyi contentofmiddleweightmoleculesintheperipheralbloodofpatientswithbraintumorsofdifferenthistostructure AT ludmilanbelskaya contentofmiddleweightmoleculesintheperipheralbloodofpatientswithbraintumorsofdifferenthistostructure AT diananstanetskaya contentofmiddleweightmoleculesintheperipheralbloodofpatientswithbraintumorsofdifferenthistostructure AT antoninaipotapova contentofmiddleweightmoleculesintheperipheralbloodofpatientswithbraintumorsofdifferenthistostructure |